WO1989002925A1 - Simultaneous assay for cholesterol and triglycerides - Google Patents

Simultaneous assay for cholesterol and triglycerides Download PDF

Info

Publication number
WO1989002925A1
WO1989002925A1 PCT/US1988/003169 US8803169W WO8902925A1 WO 1989002925 A1 WO1989002925 A1 WO 1989002925A1 US 8803169 W US8803169 W US 8803169W WO 8902925 A1 WO8902925 A1 WO 8902925A1
Authority
WO
WIPO (PCT)
Prior art keywords
cholesterol
determination
triglyceride
nad
lipase
Prior art date
Application number
PCT/US1988/003169
Other languages
French (fr)
Inventor
Diane Marian Bates
Michael A. Alejos
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to KR1019890700883A priority Critical patent/KR890701762A/en
Publication of WO1989002925A1 publication Critical patent/WO1989002925A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/28—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving peroxidase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/61—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving triglycerides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/60—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving cholesterol

Definitions

  • the present invention relates to the simultaneous measurement of a plurality of substrates with a single reagent by monitoring concurrent reactions which produce changes in the electromagnetic radiation absorbance characteristics of the sample.
  • the invention relates to the simultaneous measurement of cholesterol and triglycerides in blood ' serum by monitoring two concurrent reactions at two or more different wavelengths.
  • cholesterol and triglycerides are two of the more common tests performed in the clinical chemistry laboratory. Analysis of cholesterol is typically done using a cholesterol esterase, peroxidase (Trinder) method (Tietz, N.W., Textbook of Clinical Chemistry, 1986, p. 883).
  • Trinder method cholesterol esters are hydrolyzed by cholesterol esterase to form free cholesterol and fatty acids. The free cholesterol is then -oxidized by cholesterol oxidase which forms hydrogen peroxide. The hydrogen peroxide then reacts with peroxidase and a chromogenic oxygen acceptor to produce a color change in the 400-500 nm range.
  • Triglycerides are hydrolyzed by microbial lipase to produce glycerol and free fatty acids.
  • Glycerol and ATP in the presence of glycerol kinase form glycerol-3- phosphate + ADP.
  • the ADP from this reaction together with phosphoenolpyruvate react with pyruvate to form ATP and pyruvate.
  • the pyruvate produced reacts with lactate dehydrogenase to produce lactate, with the concomitant oxidation of NADH producing a decrease in absorbance at 340 nm. -
  • the assays mentioned above are performed with separate reagents in separate cuvettes. This costs the clinical chemistry lab time and money. By combining the two tests into one test the lab would be able to realize an increase in productivity and also a cost savings.
  • a concentration is determined for the first component. Then a . second reagent, which either quenches the first reaction or is added after the first reaction is complete, is added to the vessel to trigger a reaction with the second component. At some later time the concentration of the second component is determined. These reactions can either be monitored at the same wavelength or at different wavelengths . (either through the use of filter wheels or diode arrays).
  • U.S. Patent 3,925,162 describes the simultaneous measurement of enzyme activity in body fluids.
  • the substrate for each of the enzymes to be identified are added to a reaction medium , with other reagents and changes in the absorbance or fluorescence of the resulting reaction system are measured.
  • the present invention utilizes an approach ' where a single reagent system is used to simultaneously identify or quantify substrate by monitoring the electromagnetic signal of the reaction mixture.
  • the present invention is directed toward a method for the simultaneous determination of cholesterol and triglyceride substrates with a single reagent system in a reaction .mixture.
  • the method comprises adding a reagent system containing a reactant for each of the substrates to be determined, each reactant being selected such that it is capable of giving a unique electromagnetic radiation absorbance for the particular substrate permits calculation of both substrate concentrations.
  • the substrates are reacted with their respective reactant under conditions such that the reaction takes place simultaneously.
  • the concentration of the substrates is determined by measuring changes in absorbance or fluorescence of the resulting reaction mixture at a plurality of wavelengths which are characteristic for each of the substrates to be determined.
  • the present invention is a method for the simultaneous determination of cholesterol and triglyceride substrates with a single reagent system in a reaction mixture by adding a reagent system containing a chromophore for each of the substrates to be determined, each chromophore being selected such that it is capable of giving a unique absorbance band for the par-ticular substrate and allows the determination of the other substrate.
  • the substrates are reacted with their respective chromophore under conditions such that, the reaction takes place simultaneously.
  • the concentration of the substrates is determined by measuring changes in absorbance or fluorescence of the resulting reaction mixture at a plurality of wavelengths which are characteristic for each of the substrates to be determined.
  • the reagent system comprises an enzyme having. ⁇ cholesterol esterase activity, a chromogenic oxygen acceptor, microperoxidase, and cholesterol oxidase for determination of cholesterol; and lipase, adenosine triphosphate (ATP), phosphoenolpyruvate (PEP), glycerol kinase, pyruvate kinase, lactate dehydrogenase (LDH) and
  • NAD(P)H or analogs thereof for determination of triglyceride can be performed with a reagent system comprising lipase,
  • PEP glycerol kinase
  • pyruvate kinase LDH
  • NAD(P)H in concentrations sufficient to allow an endpoint or reaction rate determination of triglyceride.
  • the present invention relates to a method for simultaneously measuring a plurality of substrates in a biological fluid.
  • the method utilizes a single reagent for measurement of each of the substrates by monitoring •several electromagnetic signals simultaneously.
  • the electromagnetic signals can be monitored simultaneously by a spectrophotometer, or spectrofluorometer.
  • the measurement of changes in the reaction mixture can be carried out on any of the instruments by conventional procedures.
  • the particular change in the system i.e., wavelength, is not critical, but it is preferable that the changes or differences in wavelength be as great as possible provided they can be monitored simultaneously.
  • a simultaneous assay a reagent containing all the components for reaction.with the substrates to be measured are added to the sample and the reactions are monitored by the instrument.
  • a simultaneous assay is done in a single cuvette with a single reagent, eliminating the need for a second reagent dispense or other optional steps generally associated with multiple substrate assays.
  • a key to the design of a simultaneous assay is the selection of reagents that will allow the reactions to proceed simultaneously, and permit accurate determination of both analytes in the clinically relevant range.
  • Reactants are chosen for each of the substrates to be determined, such that each is capable of giving a unique electromagnetic radiation absorbance for the particular substrate.
  • a reactant can be a chromophore or indicator dye where the reaction will be monitored by spectra wavelength. For example, by choosing appropriate chromophores an assay can be developed that will measure cholesterol and triglyceride simultaneously as described below.
  • the sample is added to the reagent system which contains the appropriate reactants.
  • the reagent and sample are mixed such that each of the substrates is contacted with their respective reactant under conditions such that the reaction takes place simultaneously.
  • the addition and mixing of the sample and reagent is monitored by instrumentation appropriate for the reaction taking place such as measuring changes in absorbance or fluorescence of the resulting reaction mixture at a plurality of wavelengths which are characteristic for each of the substrates to be determined.
  • the monitoring of the reaction mixture is begun as soon as the reagent and sample are intermixed. This allows for monitoring of changes in either the reaction rate or endpoint reaction change for the particular electromagnetic signal being monitored.
  • the subject method allows for the simultaneous measurement of cholesterol and triglyceride in blood serum using a single reagent.
  • the cholesterol and triglyceride reactions proceed at the same time, with measurement of the two different reactions monitored at two separate wavelengths by a spectrophoto eter.
  • the spectrophotometer employs a diode array detector having the capability of simultaneously monitoring many wavelengths.
  • the reagent system comprises an enzyme .having cholesterol esterase activity, a chromogenic' oxygen acceptor, microperoxidase, and cholesterol oxidase for the determination of cholesterol; and lipase, adenosine triphosphate (ATP), phosphoenolpyruvate (PEP), glycerol kinase, pyruvate kinase, lactate dehydrogenase (LDH) and reduced nicotinamide-adenine dinucleotide, or reduced nicotinamide-adenine dinucleotide phosphate, jointly referred to as NAD(P)H, or analogs thereof for the determination of triglyceride.
  • ATP adenosine triphosphate
  • PEP phosphoenolpyruvate
  • LDH lactate dehydrogenase
  • NAD(P)H reduced nicotinamide-adenine dinucleotide
  • analogs thereof for the determination of
  • the measurement of cholesterol is through the use of microperoxidase to combine with hydrogen peroxide, and a chromogenic oxygen acceptor such as a guinoneimine dye with a cosubstrate such as phenol or dihydroxybenzoate whose absorbance range is between 400-500 nm.
  • a chromogenic oxygen acceptor such as a guinoneimine dye with a cosubstrate such as phenol or dihydroxybenzoate whose absorbance range is between 400-500 nm.
  • the chromogenic oxygen acceptor is 4-aminoantipyrine (4-AAP) and phenol to produce the final dye. This allows coupling the cholesterol reagent with a triglyceride reagent using NAD(P)H or analogs thereof, since microperoxidase does not oxidize
  • NAD(P)H The triglyceride reaction monitors the oxidation of NAD(P)H at 340 nm.
  • Another reagent system comprises an enzyme having cholesterol dehydrogenase activity and NAD(P)H or analogs thereof for the determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H or analogs thereof for the determination of triglyceride.
  • This reagent system is an enzyme system where chromophores are chosen for cholesterol and triglycerides which have distinguishable energy spectra such that they can be simultaneously determined.
  • Preferred chromophores for the determination of cholesterol are NAD(H), NADP(H) , thio-NAD(H) , thio-NADP(-H) , hypoxanthine-NAD(H) , hypoxanthine-NADP(H) , ' or * analogs therof.
  • Preferred chromophores for the determination of triglycerides are NAD(H) , NADP(H) , thio-NAD(H), thio-NADP(H), hypoxanthine-NAD(H) , hypoxanthine-NADP(H) , or analogs thereof.
  • the NAD or NADP chromophores can be used in either a reduced or oxidized state as either form can be used to monitor a change in absorbance or fluorescence.
  • a reagent system useful in performing the above simultaneous assay comprises lipase, ATP, glycerol kinase, pyruvate kinase, NADH, phosphoenolpyruvate and lactate dehydrogenase for the determination of triglycerides, and NADP specific cholesterol dehydrogenase and thio-NADP for the determination of cholesterol.
  • the absorbance maximum of thio-NADP is at 404 nm, with relatively little absorbance change at 340 nm.
  • a reagent system was- prepared by mixing the following (U/L is units per liter and mM is illimoles per liter): Cholate,Na 3.OmM
  • a reagent system was prepared by mixing the following:
  • a reagent system was prepared by mixing the following:
  • a reagent system was prepared by mixing the following:
  • Cholesterol/Triglyceride Simultaneous Fluorescent Assay The following procedure describes a method for performing a simultaneous assay for cholesterol and triglyceride which employs fluorescence to determine the substrate concentration.
  • a spectrofluorometer is used to monitor the simultaneous reactions.
  • the components of the assay are essentially the same as in Example 1.
  • the cholesterol part of the assay is measured by following the fluorescence emission peak as the dye is formed.
  • the triglyceride part of the assay is measured by following the fluorescence emission at 440 nm with excitation at 340 nm as NADH is oxidized to NAD.
  • Lactate Dehydrogenase (LDH) 1000U/L Sa ple is added to the reagent at a dilution ratio of
  • Sample is added to the reagent at a dilution ratio of 1:101 and the reaction is allowed to proceed.
  • the triglycerides rate of reaction is monitored at 340 nm by taking a reading every 60 seconds.
  • the cholesterol rate of reaction is monitored by taking a reading every 60 seconds. Concentrations are calculated by comparison with standard curves.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for the simultaneous determination of cholesterol and triglyceride substrates with a single reagent system. The reagent system is reacted with the specimen such that each of the substrates reacts with their respective reactant simultaneously. The change in absorbance or fluorescence of the resulting reaction mixture is measured at a plurality of wavelengths which are characteristic for each of the substrates to be determined. The amount of cholesterol and triglyceride substrates can be determined by either an endpoint or reaction rate measurement. The reagent system comprises an enzyme having cholesterol esterase activity, a chromogenic oxygen acceptor, microperoxidase, and cholesterol oxidase for determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H or analogs thereof for determination of triglyceride.

Description

SIMULTANEOUS ASSAY FOR
CHOLESTEROL AND TRIGLYCERIDES
BACKGROUND OF THE INVENTION
This is a continuation-in-part application of serial number 099,890, filed September 22, 1987.
The present invention relates to the simultaneous measurement of a plurality of substrates with a single reagent by monitoring concurrent reactions which produce changes in the electromagnetic radiation absorbance characteristics of the sample. In one aspect, the invention relates to the simultaneous measurement of cholesterol and triglycerides in blood ' serum by monitoring two concurrent reactions at two or more different wavelengths.
In the field of diagnostics, various assays are designed to identify or quantify a substrate which may be present in a. sample material. Unfortunately the assay is usually only specific to one type of substrate even though it may be desirable to diagnose more than one substrate for any given sample. This leads to multiple testing on the same sample which increases diagnosis cost and decreases efficiency. It is therefore desirable to develop diagnostic testing which can identify or quantify multiple substrates in an efficient manner.
For example, cholesterol and triglycerides are two of the more common tests performed in the clinical chemistry laboratory. Analysis of cholesterol is typically done using a cholesterol esterase, peroxidase (Trinder) method (Tietz, N.W., Textbook of Clinical Chemistry, 1986, p. 883). In the Trinder method cholesterol esters are hydrolyzed by cholesterol esterase to form free cholesterol and fatty acids. The free cholesterol is then -oxidized by cholesterol oxidase which forms hydrogen peroxide. The hydrogen peroxide then reacts with peroxidase and a chromogenic oxygen acceptor to produce a color change in the 400-500 nm range.
Analysis of triglyceride is typically done using the lipase/glycerol kinase method (Tietz, N. . , Textbook of Clinical Chemistry, 1986, p. 887). Triglycerides are hydrolyzed by microbial lipase to produce glycerol and free fatty acids. Glycerol and ATP in the presence of glycerol kinase form glycerol-3- phosphate + ADP. The ADP from this reaction together with phosphoenolpyruvate react with pyruvate to form ATP and pyruvate. The pyruvate produced reacts with lactate dehydrogenase to produce lactate, with the concomitant oxidation of NADH producing a decrease in absorbance at 340 nm. -
The assays mentioned above are performed with separate reagents in separate cuvettes. This costs the clinical chemistry lab time and money. By combining the two tests into one test the lab would be able to realize an increase in productivity and also a cost savings.
Combining the two tests is not a straightforward task. Conditions must be selected that allow precise measurement of both substrates. - For example, combination of the traditional cholesterol oxidase and triglyceride lipase/glycerol kinase methods is eliminated by the fact that peroxidase in the cholesterol reaction would oxidize the NADH in the triglyceride reaction. One way of combining the two assays in a single reaction vessel is to do a sequential assay (U.S. Patent
4,425,427 to Luderer and EP Patent 133064 to Cam et al.). In a sequential assay, reagent for the first assay is added to the vessel and the reaction proceeds.
At some later time a concentration is determined for the first component. Then a. second reagent, which either quenches the first reaction or is added after the first reaction is complete, is added to the vessel to trigger a reaction with the second component. At some later time the concentration of the second component is determined. These reactions can either be monitored at the same wavelength or at different wavelengths . (either through the use of filter wheels or diode arrays).
U.S. Patent 3,925,162 describes the simultaneous measurement of enzyme activity in body fluids. In this approach the substrate for each of the enzymes to be identified are added to a reaction medium , with other reagents and changes in the absorbance or fluorescence of the resulting reaction system are measured. The present invention utilizes an approach' where a single reagent system is used to simultaneously identify or quantify substrate by monitoring the electromagnetic signal of the reaction mixture.
SUMMARY OF THE INVENTION
The present invention is directed toward a method for the simultaneous determination of cholesterol and triglyceride substrates with a single reagent system in a reaction .mixture. The method comprises adding a reagent system containing a reactant for each of the substrates to be determined, each reactant being selected such that it is capable of giving a unique electromagnetic radiation absorbance for the particular substrate permits calculation of both substrate concentrations. The substrates are reacted with their respective reactant under conditions such that the reaction takes place simultaneously. The concentration of the substrates is determined by measuring changes in absorbance or fluorescence of the resulting reaction mixture at a plurality of wavelengths which are characteristic for each of the substrates to be determined.
In another aspect the present invention is a method for the simultaneous determination of cholesterol and triglyceride substrates with a single reagent system in a reaction mixture by adding a reagent system containing a chromophore for each of the substrates to be determined, each chromophore being selected such that it is capable of giving a unique absorbance band for the par-ticular substrate and allows the determination of the other substrate. The substrates are reacted with their respective chromophore under conditions such that, the reaction takes place simultaneously. The concentration of the substrates is determined by measuring changes in absorbance or fluorescence of the resulting reaction mixture at a plurality of wavelengths which are characteristic for each of the substrates to be determined.
The reagent system comprises an enzyme having. Λ cholesterol esterase activity, a chromogenic oxygen acceptor, microperoxidase, and cholesterol oxidase for determination of cholesterol; and lipase, adenosine triphosphate (ATP), phosphoenolpyruvate (PEP), glycerol kinase, pyruvate kinase, lactate dehydrogenase (LDH) and
NAD(P)H or analogs thereof for determination of triglyceride. The simultaneous assay can be performed with a reagent system comprising lipase,
4-aminoantipyrine, phenol, microperoxidase and cholesterol oxidase to allow for a reaction rate or endpoint determination of cholesterol; and lipase, ATP,
PEP, glycerol kinase, pyruvate kinase, LDH, and NAD(P)H in concentrations sufficient to allow an endpoint or reaction rate determination of triglyceride.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to a method for simultaneously measuring a plurality of substrates in a biological fluid. The method utilizes a single reagent for measurement of each of the substrates by monitoring •several electromagnetic signals simultaneously.
I
The electromagnetic signals can be monitored simultaneously by a spectrophotometer, or spectrofluorometer. The measurement of changes in the reaction mixture can be carried out on any of the instruments by conventional procedures. The particular change in the system ,i.e., wavelength, is not critical, but it is preferable that the changes or differences in wavelength be as great as possible provided they can be monitored simultaneously.
In a simultaneous assay a reagent containing all the components for reaction.with the substrates to be measured are added to the sample and the reactions are monitored by the instrument. Typically, a simultaneous assay is done in a single cuvette with a single reagent, eliminating the need for a second reagent dispense or other optional steps generally associated with multiple substrate assays.
A key to the design of a simultaneous assay is the selection of reagents that will allow the reactions to proceed simultaneously, and permit accurate determination of both analytes in the clinically relevant range. Reactants are chosen for each of the substrates to be determined, such that each is capable of giving a unique electromagnetic radiation absorbance for the particular substrate. A reactant can be a chromophore or indicator dye where the reaction will be monitored by spectra wavelength. For example, by choosing appropriate chromophores an assay can be developed that will measure cholesterol and triglyceride simultaneously as described below.
» After the proper reactant is chosen the sample is added to the reagent system which contains the appropriate reactants. The reagent and sample are mixed such that each of the substrates is contacted with their respective reactant under conditions such that the reaction takes place simultaneously. The addition and mixing of the sample and reagent is monitored by instrumentation appropriate for the reaction taking place such as measuring changes in absorbance or fluorescence of the resulting reaction mixture at a plurality of wavelengths which are characteristic for each of the substrates to be determined. Preferably the monitoring of the reaction mixture is begun as soon as the reagent and sample are intermixed. This allows for monitoring of changes in either the reaction rate or endpoint reaction change for the particular electromagnetic signal being monitored.
The subject method allows for the simultaneous measurement of cholesterol and triglyceride in blood serum using a single reagent. The cholesterol and triglyceride reactions proceed at the same time, with measurement of the two different reactions monitored at two separate wavelengths by a spectrophoto eter. The spectrophotometer employs a diode array detector having the capability of simultaneously monitoring many wavelengths.
Generally the reagent system comprises an enzyme .having cholesterol esterase activity, a chromogenic' oxygen acceptor, microperoxidase, and cholesterol oxidase for the determination of cholesterol; and lipase, adenosine triphosphate (ATP), phosphoenolpyruvate (PEP), glycerol kinase, pyruvate kinase, lactate dehydrogenase (LDH) and reduced nicotinamide-adenine dinucleotide, or reduced nicotinamide-adenine dinucleotide phosphate, jointly referred to as NAD(P)H, or analogs thereof for the determination of triglyceride.
The measurement of cholesterol is through the use of microperoxidase to combine with hydrogen peroxide, and a chromogenic oxygen acceptor such as a guinoneimine dye with a cosubstrate such as phenol or dihydroxybenzoate whose absorbance range is between 400-500 nm. Preferably the chromogenic oxygen acceptor is 4-aminoantipyrine (4-AAP) and phenol to produce the final dye. This allows coupling the cholesterol reagent with a triglyceride reagent using NAD(P)H or analogs thereof, since microperoxidase does not oxidize
NAD(P)H. The triglyceride reaction monitors the oxidation of NAD(P)H at 340 nm.
Another reagent system comprises an enzyme having cholesterol dehydrogenase activity and NAD(P)H or analogs thereof for the determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H or analogs thereof for the determination of triglyceride. This reagent system is an enzyme system where chromophores are chosen for cholesterol and triglycerides which have distinguishable energy spectra such that they can be simultaneously determined. Preferred chromophores for the determination of cholesterol are NAD(H), NADP(H) , thio-NAD(H) , thio-NADP(-H) , hypoxanthine-NAD(H) , hypoxanthine-NADP(H) , ' or *analogs therof. Preferred chromophores for the determination of triglycerides are NAD(H) , NADP(H) , thio-NAD(H), thio-NADP(H), hypoxanthine-NAD(H) , hypoxanthine-NADP(H) , or analogs thereof. The NAD or NADP chromophores can be used in either a reduced or oxidized state as either form can be used to monitor a change in absorbance or fluorescence.
A reagent system useful in performing the above simultaneous assay comprises lipase, ATP, glycerol kinase, pyruvate kinase, NADH, phosphoenolpyruvate and lactate dehydrogenase for the determination of triglycerides, and NADP specific cholesterol dehydrogenase and thio-NADP for the determination of cholesterol. The absorbance maximum of thio-NADP is at 404 nm, with relatively little absorbance change at 340 nm.
This allows coupling of the triglycerides reagent with the cholesterol reagent using the cholesterol dehydrogenase monitoring the reactions at the appropriate wavelengths and either endpoint or rate reactions depending upon the concentrations of the glycerol kinase and cholesterol dehydrogenase.
To further describe the instant invention the following examples are provided.
EXAMPLE 1
Cholesterol/Triglyceride Simultaneous Assay
The following procedure describes a method for performing a simultaneous assay for cholesterol and triglyceride by monitoring the endpoints of both the cholesterol and the triglyceride reactions. A reagent system was- prepared by mixing the following (U/L is units per liter and mM is illimoles per liter): Cholate,Na 3.OmM
4-Aminoantipyrine 0.8mM
Phenol 1 .OmM
Lipase 250,000U/L
Cholesterol Oxidase 117U/L
Microperoxidase 12mg/L
NADH 0. mM
Phosphoenolpyruvate (PEP) 0.7mM
Adenosine triphosphate (ATP) 0.06mM
MgS04 ' 5.5mM
Tris buffer lOOmM
Succinic Acid 26mM
Pyruvate Kinase 1667U/L
Glycerol Kinase 667U/L
Lactate Dehydrogenase (LDH) 1000U/L Sample was added to the reagent at a ratio of 1:101 and the reaction was allowed to proceed. After 3 minutes the absorbance was read at 340 nm and at 500 nm. Concentrations were calculated by comparison with standard curves.
EXAMPLE 2
Cholesterol/Triglyceride Simultaneous Assay
The following procedure describes a method for performing a simultaneous assay for cholesterol and triglyceride by monitoring the cholesterol rate of reaction and the triglyceride reaction endpoint. A reagent system was prepared by mixing the following:
Cholate,Na 3.OmM
4-Aminoantipyrine (4-AAP) 0.8mM
Phenol 14.OmM
Lipase 250,000U/L
Cholesterol Oxidase 10U/L
Microperoxidase 12mg/L
NADH 0.4mM
Phosphoenolpyruvate (PEP) 0.7mM
ATP 0.06mM
MgS04 5.5mM
Tris buffer lOOmM
Succinic Acid 26mM
Pyruvate Kinase 1667U/L
Glycerol Kinase 667U/L
Lactate Dehydrogenase (LDH) 1000U/L
Sample was added to the reagent at a ratio of 1:101 and the reaction was allowed to proceed. The cholesterol rate of reaction was monitored at 500 nm by taking a reading every 60 seconds for three minutes, starting at 60 seconds. After 3 minutes the absorbance is read at 340 nm. Concentrations are calculated by comparison with standard curves.
EXAMPLE 3
Cholesterol/Triglyceride Simultaneous Assay
The following procedure describes a method for performing a simultaneous assay for cholesterol and triglyceride by monitoring the cholesterol reaction endpoint and the triglyceride reaction rate. A reagent system was prepared by mixing the following:
Cholate,Na
4-Aminoantipyrine
Phenol
Lipase
Cholesterol Oxidase
Microperoxidase
NADH
Ptrosphoeno Ipyruvate
ATP
MgS04
Tris buffer
Succinic Acid
Pyruvate Kinase
Glycerol Kinase
LDH
Figure imgf000013_0001
Sample was added to the reagent at a ratio of 1:101 and the reaction was allowed to proceed. The triglyceride was followed at 340 nm by reading every 60 seconds for three minutes. After 3 minutes the absorbance is read at 500 nm. Concentrations were calculated by comparison with standard curves. EXAMPLE 4 -12-
Cholesterol/Triglyceride Simultaneous Assay
The following procedure describes a method for performing a simultaneous assay for cholesterol and triglyceride by monitoring the cholesterol reaction rate and the triglyceride reaction rate. A reagent system was prepared by mixing the following:
Cholate,Na 3.OmM
4-Aminoantipyrine 0.8mM
Phenol 14.OmM
Lipase 250,000U/L
Cholesterol Oxidase 10U/L
Microperoxidase 12mg/L
NADH 0. mM
Phosphoenolpyruvate 0.7mM
ATP 0.06mM
MgS04 5.5mM
Tris,buffer lOOmM Succinic Acid 26mM Pyruvate Kinase 1667U/L Glycerol Kinase 60U/L LDH 1000U/L
Sample was added to the reagent at a ratio of 1:101 and the reaction was allowed to proceed. Every 60 seconds for three minutes the absorbance is read at 500 nm and at 340 nm. Concentrations were calculated by comparison with standard curves.
EXAMPLE 5
Cholesterol/Triglyceride Simultaneous Fluorescent Assay The following procedure describes a method for performing a simultaneous assay for cholesterol and triglyceride which employs fluorescence to determine the substrate concentration. In this method a spectrofluorometer is used to monitor the simultaneous reactions. The components of the assay are essentially the same as in Example 1. The cholesterol part of the assay is measured by following the fluorescence emission peak as the dye is formed. The triglyceride part of the assay is measured by following the fluorescence emission at 440 nm with excitation at 340 nm as NADH is oxidized to NAD.
EXAMPLE 6 Endpoint/Endpoint
Cholesterol Dehydrogenase 20,000U/L thio-NADP 0.25mM
NADH 0.40mM .Phosphoenolpyruvate 0.70mM
Adenosine triphosphate 0.06mM
MgS04 5.5mM *
Tris buffer lOOmM
Succinic Acid 26mM
Pyruvate Kinase 1667U/L
Glycerol Kinase 667U/L
Lactate Dehydrogenase (LDH) 1000U/L
Sample is added to the reagent at a dilution ratio of 1:101 and the reaction is allowed to proceed. After 3 minutes the absorbance is read at 340 nm and 404 nm. Concentrations are calculated by comparison with standard curve. EXAMPLE 7 ~14~
Cholesterol Endpoint/Triglycerides Rate
Cholesterol Dehydrogenase 20,000ϋ/L thio-NADP 0.25mM
NADH 0.40mM
Phosphoenolpyruvate 0.70mM
Adenosine triphosphate 0.06mM
MgS04 5.5mM
Tris buffer lOO M
Succinic Acid 26mM
Pyruvate Kinase 1667U/L
Glycerol Kinase 60U/L
Lactate Dehydrogenase (LDH) 1000U/L
Sample is added to the reagent at a dilution ratio of 1:101 and the reaction is allowed to proceed. The triglycerides rate of reaction is monitored at 340 nm by taking a.reading every 60 seconds. After 3 minutes the 'absorbance is read at 404 nm. Concentrations are calculated by comparison with standard curves.
EXAMPLE 8
Cholesterol Rate/Triglycerides Endpoint
Cholesterol Dehydrogenase 2000U/L thio-NADP 0.25mM
NADH 0.40mM
PhosphoenoIpyruvate 0.70mM
Adenosine triphosphate 0.06mM
MgS04 5.5mM
Tris buffer lOOmM
Succinic Acid 26mM
Pyruvate Kinase 1667U/L
Glycerol Kinase 667U/L
Lactate Dehydrogenase (LDH) 1000U/L Sa ple is added to the reagent at a dilution ratio of
1:101 and the reaction is allowed to proceed. The cholesterol rate of reaction is monitored at 404 nm by taking a reading every 60 seconds. ' After 3 minutes the absorbance is read at 340 nm. Concentrations are calculated by comparison with standard curves.
EXAMPLE 9
Cholesterol Rate/Triglycerides Rate
Cholesterol Dehydrogenase 2000U/L thio-NADP 0.25mM
NADH 0.40mM
Phosphoenolpyruvate 0.70mM
Adenosine triphosphate 0.06mM
MgS04 5.5mM
Tris buffer lOOmM
Succinic Acid 26mM
Pyruvate Kinase 1667U/L
Glycerol Kinase 60U/L
Lactate Dehydrogenase (LDH) 1000U/L
Sample is added to the reagent at a dilution ratio of 1:101 and the reaction is allowed to proceed. The triglycerides rate of reaction is monitored at 340 nm by taking a reading every 60 seconds. The cholesterol rate of reaction is monitored by taking a reading every 60 seconds. Concentrations are calculated by comparison with standard curves.

Claims

WE CLAIM: -16-
1. A method for the simultaneous determination of cholesterol and triglyceride substrates with a single reagent system in a reaction mixture, comprising: adding a reagent system containing a reactant for each of the substrates to be determined, each reactant being selected such that it is capable of giving a unique electromagnetic radiation absorbance for the particular substrate and permits the determination of the other substrate; simultaneously reacting each of the substrates with their respective reactant under conditions such that the reaction takes place simultaneously; and measuring changes in absorbance or fluorescence of the resulting reaction mixture at a plurality of wavelengths which are characteristic for each of the substrates to be determined.
2. -A method for the simultaneous determination of cholesterol and triglyceride substrates with a single reagent system in a reaction mixture, comprising: adding a reagent system containing a chromophore for each of the substrates to be determined, each chromophore being selected such that it is capable of giving a unique absorbance band for the particular substrate which permits determination of the other substrate; simultaneously reacting each of the substrates with their respective chromophore under conditions such that the reaction takes place simultaneously; and measuring changes in absorbance or fluorescence of the resulting reaction mixture at a plurality of wavelengths which are characteristic for each of the substrates to be determined.
3. The method of Claim 2 wherein said reagent system comprises an enzyme having cholesterol esterase activity, a chromogenic oxygen acceptor, microperoxidase, and cholesterol oxidase for determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H or analogs thereof for determination of triglyceride.
4. The method of Claim 3 wherein said reagent system comprises lipase, 4-AAP, phenol, microperoxidase, cholesterol oxidase in a concentration sufficient to allow an endpoint determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H in a concentration sufficient to allow an endpoint determination of triglyceride.
5. The method of Claim 3 wherein said reagent system comprises lipase, 4-AAP, phenol, microperoxidase, cholesterol oxidase in a concentration sufficient to allow a rate determination of cholesterol; and lipase,- ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H in a concentration sufficient to allow an endpoint determination of triglyceride.
6. The method of Claim 3 wherein said reagent system comprises lipase, 4-AAP, phenol, microperoxidase, cholesterol oxidase in a concentration sufficient to allow an endpoint determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H in a concentration sufficient to allow a rate determination of triglyceride.
7. The method of Claim 3 wherein said reagent system comprises lipase, 4-AAP, phenol, microperoxidase, cholesterol oxidase in a concentration sufficient to allow a rate determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H in a concentration sufficient to allow a rate determination of triglyceride.
8. The method of Claim 2 wherein said reagent system comprises an enzyme having cholesterol dehydrogenase activity and NAD(P)H or analogs thereof for determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H or analogs thereof for determination of triglyceride.
9. The method of Claim 9 wherein said reagent system comprises an enzyme having cholesterol dehydrogenase activity and NAD(P)H or analogs thereof in a concentration sufficient to allow an endpoint determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate^kinase, LDH and NAD(P)H or analogs thereof in a concentration sufficient to allow an endpoint determination of triglyceride.
10. The method of Claim 9 wherein said reagent system comprises an enzyme having cholesterol dehydrogenase activity and NAD(P)H or analogs thereof in a concentration sufficient to allow a rate determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H in analogs thereof in a concentration sufficient to allow an endpoint determination of triglyceride.
11. The method of claim 9 wherein said reagent system comprises an enzyme having cholesterol dehydrogenase activity and NAD(P)H or analogs thereof in a concentration sufficient to allow an endpoint determination of cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H or analogs thereof in a concentration sufficient to allow a rate determination of triglyceride.
12. The method of claim 9 wherein said reagent system comprises an enzyme having cholesterol dehydrogenase activity and NAD(P)H or analogs thereof in at concentration sufficient to allow a rate determination of" cholesterol; and lipase, ATP, PEP, glycerol kinase, pyruvate kinase, LDH and NAD(P)H or analogs thereof in a concentration sufficient to allow a rate determination of triglyceride.
13. A reagent system for the simultaneous determination of cholesterol and triglyceride as described in Claim 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12.
PCT/US1988/003169 1987-09-22 1988-09-20 Simultaneous assay for cholesterol and triglycerides WO1989002925A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019890700883A KR890701762A (en) 1987-09-22 1988-09-20 Simultaneous assay of cholesterol and triglycerides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9989087A 1987-09-22 1987-09-22
US099,890 1987-09-22

Publications (1)

Publication Number Publication Date
WO1989002925A1 true WO1989002925A1 (en) 1989-04-06

Family

ID=22277116

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1988/003169 WO1989002925A1 (en) 1987-09-22 1988-09-20 Simultaneous assay for cholesterol and triglycerides

Country Status (6)

Country Link
EP (1) EP0395654A4 (en)
JP (1) JPH01108998A (en)
KR (1) KR890701762A (en)
AU (2) AU2486388A (en)
CA (1) CA1323554C (en)
WO (1) WO1989002925A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049247A3 (en) * 1999-12-30 2002-01-31 Specialty Assays Inc Assays for analytes and enzymes practiced in the presence of nad and nadp analogues, and related assay kits
US6737275B2 (en) 2001-02-05 2004-05-18 The Board Of Regents For Oklahoma State University Direct serum lipids assays for evaluation of disease states

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925164A (en) * 1973-03-28 1975-12-09 Boehringer Mannheim Gmbh Method for the determination of cholesterol
US4309502A (en) * 1980-06-30 1982-01-05 Beckman Instruments, Inc. Enzymatic assay for glycerol and triglycerides and a reagent for use therein
US4425427A (en) * 1980-03-13 1984-01-10 Vitafin N.V. Simultaneous, kinetic, spectrophotometric analysis of blood serum for multiple components
FR2547925A1 (en) * 1983-06-23 1984-12-28 Biotrol Sa Lab PROCESS FOR THE SUCCESSIVE ASSAY OF VARIOUS COMPONENTS OF A BIOLOGICAL SPECIMEN FROM THE SAME TEST IN THE SAME REACTION ENCLOSURE AND REAGENTS USED THEREFOR

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925164A (en) * 1973-03-28 1975-12-09 Boehringer Mannheim Gmbh Method for the determination of cholesterol
US4425427A (en) * 1980-03-13 1984-01-10 Vitafin N.V. Simultaneous, kinetic, spectrophotometric analysis of blood serum for multiple components
US4309502A (en) * 1980-06-30 1982-01-05 Beckman Instruments, Inc. Enzymatic assay for glycerol and triglycerides and a reagent for use therein
FR2547925A1 (en) * 1983-06-23 1984-12-28 Biotrol Sa Lab PROCESS FOR THE SUCCESSIVE ASSAY OF VARIOUS COMPONENTS OF A BIOLOGICAL SPECIMEN FROM THE SAME TEST IN THE SAME REACTION ENCLOSURE AND REAGENTS USED THEREFOR

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP0395654A4 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6380380B1 (en) 1999-01-04 2002-04-30 Specialty Assays, Inc. Use of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucliotide phosphate (NADP) analogs to measure enzyme activities metabolites and substrates
WO2001049247A3 (en) * 1999-12-30 2002-01-31 Specialty Assays Inc Assays for analytes and enzymes practiced in the presence of nad and nadp analogues, and related assay kits
US6737275B2 (en) 2001-02-05 2004-05-18 The Board Of Regents For Oklahoma State University Direct serum lipids assays for evaluation of disease states

Also Published As

Publication number Publication date
EP0395654A1 (en) 1990-11-07
AU2486388A (en) 1989-04-18
AU2280892A (en) 1992-11-19
CA1323554C (en) 1993-10-26
JPH01108998A (en) 1989-04-26
EP0395654A4 (en) 1991-01-09
KR890701762A (en) 1989-12-21

Similar Documents

Publication Publication Date Title
CA1318228C (en) Simultaneous assay for glucose and urea
US4743561A (en) Luminescent assay with a reagent to alter transmitive properties of assay solution
US4490465A (en) Coupled enzyme systems for determination of dissolved substances
EP0033462A1 (en) Aminopyrine improved Trinder's reagent and dosing process for hydrogen peroxide from enzimatic oxidation of metabolic substrata with the same
Shephard et al. Falsely low estimation of triglycerides in lipemic plasma by the enzymatic triglyceride method with modified Trinder's chromogen
EP0116307B1 (en) Composition, analytical element and method for the quantification of creatine kinase
Wimmer et al. A kinetic colorimetric procedure for quantifying magnesium in serum.
CA1323554C (en) Simultaneous assay for cholesterol and triglyceride
EP0639646A1 (en) High precision determination of d-glucose-6-phosphate and composition therefor
JPH0646896A (en) Dry analyzing element for detecting acidic phosphatase of prostata and its detecting method
Smith et al. Automated measurement of total cholesterol and triglycerides, in" tandem," on the discrete sample analyzer, Gilford System 3500.
EP1678318A2 (en) Detection of potassium ions using ion-sensitive enzymes
Hearne et al. Assessment of colorimetric enzymatic determination of triglyceride, by manual and centrifugal analyzer techniques, and comparison with a CDC standardized method
WO1997039352A1 (en) Assays for detection of purine metabolites
JPS62195297A (en) Reagent for determining calcium ion
JP3034984B2 (en) Highly sensitive method and composition for quantification of D-galactose
Pitkänen et al. A quantitative fluorometric micromethod used for the neonatal screening of biotinidase deficiency in Finland
Kusu et al. Fluorometric determination of pseudocholinesterase activity in postmortem blood samples
JPH0731498A (en) Determination kit for 1,5-anhydroglucitol and determination method using the kit
JPH06237795A (en) Determination of 1,5-anhydroglucitol
RU1788467C (en) Method for cholesterine determination
JP2643205B2 (en) Highly sensitive colorimetric method
JP3402487B2 (en) Determination of 1,5-anhydroglucitol
JPH06237794A (en) Determination of 1,5-anhydroglucitol
JPH03285697A (en) Method for testing chemoluminescence

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LU NL SE

WWE Wipo information: entry into national phase

Ref document number: 1988908629

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1988908629

Country of ref document: EP

WWR Wipo information: refused in national office

Ref document number: 1988908629

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1988908629

Country of ref document: EP